Sfoglia per AUTORE
CERVERA R
Collezione ASL Città di Torino

  

Items : 6

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 18:keae583. doi: 10.1093/rheumatology/keae583.

2024
ASL Città di Torino

Cecchi I; Radin M; Foddai SG; Barinotti A; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Lopez Pedrera C; Fortin PR; Gerosa M; de Jesus G; Atsumi T; Ji L; Efthymiou M; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri M; Cervera R; Knight J; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Erkan D; Sciascia S;

Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus. in Autoimmunity reviews / Autoimmun Rev. 2024 Jul-Aug;23(7-8):103581. doi: 10.1016/j.autrev.2024.103581. Epub 2024 Jul 26.

2024
ASL Città di Torino

Yan Q; Tzioufas AG; Trunfio F; Triolo G; Sebastiani G; Selmi C; Shoenfeld Y; Sarzi-Puttini P; Scarpa R; Rivellese F; Priori R; Pontarini E; Prete M; Pitzalis C; Pilato A; Perosa F; Perricone C; Orefice V; Occhialini D; Naty S; Navarini L; Montecucco C; Mosca M; Mauro D; Manoussakis MN; Marino A; Liakouli V; Iaquinta FS; Iagnocco A; et alii...

2023 ACR/EULAR antiphospholipid syndrome classification criteria. in Annals of the rheumatic diseases / Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28.

2023
ASL Città di Torino

Sciascia S; Seshan SV; Roubey R; Sanna G; Raimboug Q; Gomez-Puerta JA; Pengo V; Petri M; Pons-Estel G; Orsolini G; Ortel TL; Meroni PL; Musial J; Mayer-Pickel K; Lockshin MD; Limper M; Levy RA; Levine SR; Legault K; Laskin C; Lee AI; Knight JS; Kello N; Leaf RK; Jordan N; Gris JC; Garcia D; Frances C; Duarte-García A; et alii...

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2023 Oct;75(10):1687-1702. doi: 10.1002/art.42624. Epub 2023 Aug 28.

2023
ASL Città di Torino

Sciascia S; Seshan SV; Sanna G; Roubey R; Raimboug Q; Gomez-Puerta JA; Petri M; Pons-Estel G; Pengo V; Ortel TL; Orsolini G; Meroni PL; Musial J; Mayer-Pickel K; Lockshin MD; Limper M; Levy RA; Levine SR; Laskin C; Lee AI; Legault K; Knight JS; Kello N; Leaf RK; Jordan N; Garcia D; Gris JC; Frances C; Duarte-Garcia A; et alii...

ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):543-553. doi: 10.55563/clinexprheumatol/jpargp. Epub 2023 Mar 14.

2023
ASL Città di Torino

Smith V; Scirè CA; Simonini G; Sciascia S; Schneider M; Romão VC; Richez C; Rednic S; Pistello M; Pileckyte M; Pamfil C; Olesinska M; Nagy G; Moroncini G; Marinello D; Meyer A; Limper M; Khmelinskii N; Jacobsen S; Iaccarino L; Galetti I; Hachulla E; Fonseca JE; Faria R; Damian L; Della-Torre E; Cutolo M; Cervera R; Callens S; et alii...

Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion? in Autoimmunity reviews / Autoimmun Rev. 2017 Nov;16(11):1109-1114. doi: 10.1016/j.autrev.2017.09.004. Epub 2017 Sep 9.

2017
ASL Città di Torino

Cervera R; Meroni PL; López-Pedrera C; Espinosa G; Bertolaccini ML; Coloma-Bazán E; Radin M; Sciascia S; Cuadrado MJ;